Here’s where we will share current and exciting information about acute care diagnostics, innovative biomarkers, recent research and development stories. We will also have guest bloggers to bring unique perspectives on happenings in life sciences and personalized medicine. Stay tuned, and sign up for our newsletter that informs you about the latest blog topics we cover.
Liberation from Renal Replacement Therapy in Acute Kidney Injury patients: The current routine and insights into the future
The decision to stop RRT is a critical step that necessitates careful consideration of various clinical parameters. Currently, the liberation rocess is informed by changes in traditional kidney function markers, such as serum creatinine and urine output, in conjunction with the patient's clinical status.
SphingoTec has discovered Proenkephalin A 119-159 (penKid), a biomarker with a strong body of evidence on its relevance and added value to the AKI diagnosis augmented by its strong performance in the clinical routine.
In this interview, Prof. Peter Pickkers (Radboud University Medical Center, Nijmegen) highlights the research background on the novel kidney function biomarker Proenkephalin A 119-159, including a new formula for the glomerular filtration rate (GFR) based on this biomarker.
Patients suffering from one particular disease are often treated with the same drug – independent of their age, gender, origin, or even the underlying disease mechanisms, which can vary greatly among different patients. In the field of personalized medicine, these differences are considered with the aim of providing individualized treatment to help the patient with the best possible outcome.
Is it possible to find the best-fitting medication for each individual? Find out more about the importance of diagnostics in personalized medicine in our blog post.
„Could it be sepsis? The DeutschlandErkenntSepsis campaign highlights the importance of knowing the signs and symptoms of sepsis to reduce preventable deaths from sepsis and improve outcomes for survivors. Read more in our blog post.
Can point-of-care testing be an alternative to conventional laboratory testing? Learn more about the bed-side solution to a health care challenge in our blog post.
Acute kidney injury (AKI) is featured by acute deterioration in renal function, defined by changes in serum creatinine (SCr), urine output, or both. As one syndrome, AKI encompasses a wide variety of causes and risk factors, leading to a decline in kidney function or renal damage.